use it in vaccines, to “train” a person’s immune system to recognize and fight the virus.Recently, a team of investigators from the University of Texas at Austin has created a version of the SARS-CoV-2 spike protein that, they argue, might help bring vaccines to more people faster.Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.According to senior author Jason McLellan, associate professor in the Department of Molecular Biosciences:“Depending on the type of vaccine, this improved version of the protein could reduce the size of each dose or speed up vaccine production.